Building on our 2017 Antibiotics Commitment, which outlined five key principles to improve animal health and responsible antibiotic use, we see a way forward that addresses AMR through reducing the need for antibiotics.

This Roadmap focuses on the actions the public and private sectors can undertake to reduce the need for antibiotics in animals. This includes better prevention, earlier diagnostics, increased access to innovative treatments, and more.

In this section are the cumulative actions that HealthforAnimals and our Members, will undertake between now and 2025. HealthforAnimals will regularly survey our Members to track progress on the Roadmap and release updates.

However, we cannot achieve this alone. Read on to section 4 to see how policymakers and international organizations can also take action that can help reduce the need for antibiotics in animals.

Our Actions

Addressing AMR is a difficult, global challenge. But we believe reducing the need for antibiotics is an essential part, and this will require strong action and accountability.

HealthforAnimals and our Members, representing more than 85 percent of the animal medicines industry, pledge to collaboratively undertake the following clear, measurable actions to improve the three areas of our vision – prevention, detection and treatment – by 2025:

Research & development

If we are to continue to maintain and improve animal health as well as reduce the need for antibiotics, we will need new innovations that help keep animals healthier, preserve welfare, diagnose disease earlier and treat illness more accurately.

To help achieve this, we will:

  • Invest at least $10 billion in research and development
  • Deliver at least 100 new vaccines
  • Deliver at least 20 new diagnostics tools
  • Deliver at least 20 new nutritional enhancement products
  • Deliver at least 30 other products that can reduce the need for an antimicrobial by reducing animal stress or boosting the natural immune system (ex. parasiticides, immunostimulants, anthelmintic, etc.)

One Health

In addressing issues such as AMR, we must recognize that this is not an issue limited by species or location. AMR affects animals, people and the planet, and can only be addressed through working across these disciplines.

To help achieve this, we will:

  • Deliver tools that reduce the likelihood of human exposure to a resistant pathogen such as Salmonella, Campylobacter, or E. coli
  • Conduct an AMR risk analysis for every new antibiotic brought to market


Reducing the need for antibiotics can only be possible when the importance, benefits, scientific basis, and methods are properly communicated.

To help achieve this, we will:

  • Strengthen communications on benefits of biosecurity, in-feed supplements, vaccinations, and products that support good animal health
  • Participate in forums and public dialogues to help build understanding of risks, benefits, and actions that different stakeholders can take to improve public health outcomes in the fight against AMR
  • Issue regular report(s) and/or white paper(s) identifying barriers to adoption of prevention tools (e.g. vaccination, biosecurity, etc) and how they can be addressed
  • Issue Roadmap Updates in 2021 and 2023

Veterinary training & access

Veterinarians and veterinary paraprofessionals are on the frontline of the battle against AMR, using their expertise and knowledge to make a difference. They are trained to use antibiotics in a responsible manner that reduces animal suffering while limiting the emergence of resistance. Contributing to greater veterinary training and access can make all the difference in upholding animal health.

To do this, we will:

  • Provide clear labels on every, single product
  • Make technical guidance available to all product users
  • Train more than 100, 000 veterinarians in responsible use of medicines
  • Undertake at least 15 veterinary training partnerships
  • Invest at least $5 million in veterinary education scholarships and grants
  • Deliver a white paper on opportunities in telemedicine for improving access to veterinarians in high-income and low and middle income nations


The animal medicines industry does not work in a vacuum and we cannot address animal health alone. We will redouble efforts to build partnerships and work across disciplines to reduce the need for antibiotics.

To do this, we will:

  • Participate in responsible use coalitions in major markets
  • Share sales data in every market where it is required
  • Undertake five new partnerships that deliver products that help to reduce the need for antibiotics in underserved markets
  • Conduct at least 50 audits of active ingredient suppliers to ensure they are meeting appropriate standards
  • Encourage medicine users to submit efficacy reports into pharmacovigilance monitoring systems


Addressing AMR will be more successful with greater knowledge and understanding about its origins, development, movement and contributory factors.

To support this, we will:

  • Provide research grants of at least $1 million
  • Publish new, scientific research within peer-reviewed publications which improves understanding of veterinary pathogens or antimicrobial resistance
  • Provide data and support to help improve disease tracking to organizations such as the World Organisation for Animal Health (OIE)